Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 25.5B | 31.4B | 24.3B | 25.9B |
Cost of revenue | 18.3B | 22.2B | 17.6B | 18.7B |
Gross profit | 7.2B | 9.1B | 6.7B | 7.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | 190.3M | 209.4M |
Other operating expenses | 2.0B | 2.4B | 1.7B | 1.6B |
Operating income | 1.9B | 3.6B | 1.7B | 2.3B |
Non operating interest income | ||||
Income | — | — | 42.2M | 33.5M |
Expense | 493.1M | 314.8M | 342.5M | 341.7M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 3.5B | 1.4B | 2.0B |
Tax provision | 406.2M | 891.9M | 368.9M | 506.3M |
Net income | 1.2B | 2.6B | 1.0B | 1.5B |
Basic EPS | — | 0.6 | — | 0.3 |
Diluted EPS | — | 0.6 | — | 0.3 |
Basic average shares | — | 4.5B | — | 4.5B |
Diluted average shares | — | 4.6B | — | 4.5B |
EBITDA | 3.8B | 5.2B | 3.1B | 3.7B |
Net income from continuing op. | — | — | 1.4B | 2.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |